Comparison of Two Strategies for Prophylactic Donor Lymphocyte Infusion in Patients With Refractory/Relapsed Acute Leukemia

Comparison of Two Strategies for Prophylactic Donor Lymphocyte Infusion in Patients With Refractory/Relapsed Acute Leukemia

Prophylactic donor lymphocyte infusion (pDLI) could reduce relapse in patients with refractory/relapsed acute leukemia (RRAL) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), but optimal timing of pDLI remains uncertain. We compared the outcomes of two strategies for pDLI b...

Full description

Bibliographic Details
Main Authors: Qiongqiong Su, Zhiping Fan, Fen Huang, Na Xu, Danian Nie, Dongjun Lin, Ziwen Guo, Pengcheng Shi, Zhixiang Wang, Ling Jiang, Jing Sun, Zujun Jiang, Qifa Liu, Li Xuan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
prophylactic donor lymphocyte infusion
refractory/relapsed acute leukemia
relapse
allogeneic hematopoietic stem cell transplantation
minimal residual disease
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.554503/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.554503/full

Similar Items